EP300 and colorectal cancer: However, treatment with a mild insult (2% DSS), while having minimal effects on wild type C57BL/6 mice, had a striking effect on the p300 S89A mice as evidenced by the development in the p300 S89A mice of severe colitis, a significant risk factor predisposing to colorectal cancer [27,28] (Figure 3A,B).